Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients

Percentage of patients aged 18 through 80 years with AJCC Stage III colon cancer who are referred for adjuvant chemotherapy, prescribed adjuvant chemotherapy, or have previously received adjuvant chemotherapy within the 12-month reporting period.

 

Measure Steward

American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)

 

Measure Numerator

Patients who are referred for adjuvant chemotherapy, prescribed adjuvant chemotherapy, or who have previously received adjuvant chemotherapy within the 12 month reporting period.

 

Measure Denominator

All patients aged 18 through 80 years with colon cancer with AJCC Stage III colon cancer.